Outcome of COVID-19 patients with use of Tocilizumab: A single center experience

COVID-19 pandemic has become a global concern. Cytokine release syndrome (CRS) complicates acute respiratory distress syndrome (ARDS) and causes multi-organ failure which can subsequently lead to mortality in COVID-19 patients. Tocilizumab, an interleukin-6 antagonist, has shown to salvage patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zain Mushtaq, Muhammad, Bin Zafar Mahmood, Saad, Jamil, Bushra, Aziz, Adil, Ali, Syed Ahsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455148/
https://www.ncbi.nlm.nih.gov/pubmed/32889236
http://dx.doi.org/10.1016/j.intimp.2020.106926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455148/
https://www.ncbi.nlm.nih.gov/pubmed/32889236
http://dx.doi.org/10.1016/j.intimp.2020.106926

Ejemplares similares